This suggests that SGLT2 inhibition can prevent NPs-induced endothelial dysfunction, at least in part, by preventing the down-regulation of eNOS expression and by stimulating eNOS enzymatic activity. This evidence concerns the gene SLC5A2 and endothelial dysfunction.